Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 28, 2020; 26(8): 828-838
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.828
Table 3 Univariate and multivariate analysis for overall survival in subgroups of patients with resected pancreatic cancer
FeaturesOS
RFS
Univariate analysis
Multivariate analysis
Univariate analysis
Multivariate analysis
HR95%CIP valueHR95%CIP valueHR95%CIP valueHR95%CIP value
Age0.8740.683-1.1190.286NS0.8960.737-1.0900.273NS
Gender (male versus female)1.3121.021-1.6860.034NS1.1960.982-1.4560.075NS
Tumor location (body/tail versus head)0.9250.722-1.1850.538NS0.9760.806-1.1880.805NS
Preoperative CA19-9 (> 37 U/mL/≤ 37 U/mL)1.8711.355-2.585< 0.0011.6291.176-2.2580.0031.5431.218-1.955< 0.0011.451.143-1.8390.002
HALP (> 44.56/≤ 44.56)0.6050.472-0.774< 0.0010.6010.433-0.835< 0.0010.6330.520-0.772< 0.0010.6780.556-0.828< 0.001
NLR (> 2.20/≤ 2.20)1.6541.289-2.122< 0.0011.3941.062-1.8310.0171.4421.185-1.754< 0.001NS
PLR (> 112.94/≤ 112.94)1.2720.990-1.6340.06NS1.2771.047-1.5570.016NS
PNI (> 53.10/≤ 53.10)0.6630.511-0.8600.002NS0.7641.650-1.9700.024NS
TNM stage (III/IIB/IIA/IB/IA)1.391.240-1.558< 0.0011.3021.161-1.461< 0.0011.2941.184-1.413< 0.0011.2361.132-1.350< 0.001
Tumor size (> 4.0/≤ 4.0 cm)1.5861.237-2.034< 0.001NA1.3341.092-1.6300.005NA
Lymph node metastasis (more than 3/1-3/0 nodes)1.6581.395-1.970< 0.001NA1.5331.334-1.761< 0.001NA
Total lymph nodes resected0.9920.979-1.0060.246NS1.0010.991-1.0110.868NS
Differentiation (well, moderate versus poor)2.1921.711-2.808< 0.0011.9881.547-2.555< 0.0011.7911.467-2.187< 0.0011.6721.367-2.043< 0.001
Neural invasion (yes versus no)1.5331.078-2.1820.018NS1.3581.041-1.7720.024NS
Microvascular invasion (yes versus no)1.4241.070-1.8940.015NS1.3061.037-1.6460.024NS